Inventor · disambiguated record
Anna-Maria A. Hays Putnam
Also filed as: HAYS PUTNAM ANNA-MARIA A
25 granted patents·11 pending applications·425 citations·filing 2006–2022
97Inventor score
Top patents by PatentIndex Score
36 records- 0198US8053560B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Nov 8, 2011·40 cites·5 claims
- 0298US8012931B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2008·Granted Sep 6, 2011·76 cites·52 claims
- 0398US7919591B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Apr 5, 2011·41 cites·1 claims
- 0496US8618257B2Modified human plasma polypeptide or Fc scaffolds and their usesSHEFFER JOSEPH·Filed 2007·Granted Dec 31, 2013·32 cites·4 claims
- 0596US8383365B2Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivativesAMBRX INC·Filed 2011·Granted Feb 26, 2013·48 cites·60 claims
- 0696US8022186B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Sep 20, 2011·20 cites·5 claims
- 0795US8232371B2Modified human interferon polypeptides and their usesCHO HO SUNG·Filed 2011·Granted Jul 31, 2012·23 cites·13 claims
- 0894US9975936B2Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2016·Granted May 22, 2018·12 cites·20 claims
- 0994US9079971B2Modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2013·Granted Jul 14, 2015·19 cites·39 claims
- 1093US9517273B2Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2015·Granted Dec 13, 2016·15 cites·20 claims
- 1192US8569233B2Modified animal erythropoietin polypeptides and their usesTIAN FENG·Filed 2012·Granted Oct 29, 2013·17 cites·15 claims
- 1292US8329869B2Modified interferon beta polypeptides and their usesKRAYNOV VADIM·Filed 2012·Granted Dec 11, 2012·21 cites·6 claims
- 1392US8278418B2Modified animal erythropoietin polypeptides and their usesTIAN FENG·Filed 2009·Granted Oct 2, 2012·21 cites·12 claims
- 1490US8114630B2Modified interferon beta polypeptides and their usesKRAYNOV VADIM·Filed 2008·Granted Feb 14, 2012·18 cites·4 claims
- 1586US10961291B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2019·Granted Mar 30, 2021·1 cites·26 claims
- 1684US10377805B2Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their usesAMBRX INC·Filed 2018·Granted Aug 13, 2019·2 cites·21 claims
- 1784US8946148B2Modified insulin polypeptides and their usesMIAO ZHENWEI·Filed 2008·Granted Feb 3, 2015·6 cites·3 claims
- 1882US9644014B2Modified animal erythropoietin polypeptides and their usesAMBRX INC·Filed 2015·Granted May 9, 2017·3 cites·12 claims
- 1982US9488660B2Methods and compositions comprising non-natural amino acidsMIAO ZHENWEI·Filed 2010·Granted Nov 8, 2016·3 cites·2 claims
- 2077US11993637B2Modified FGF-21 polypeptides with non-naturally encoded amino acidsAMBRX INC·Filed 2021·Granted May 28, 2024·0 cites·20 claims
- 2177US9156899B2Modified animal erythropoietin polypeptides and their usesAMBRX INC·Filed 2013·Granted Oct 13, 2015·2 cites·11 claims
- 2277US9074010B2Modified human plasma polypeptide or Fc scaffolds and their usesSHEFFER JOSEPH·Filed 2011·Granted Jul 7, 2015·1 cites·4 claims
- 2375US2023348547A1Modified bovine g-csf polypeptides and their usesAMBRX INC·Filed 2022·Application pending·0 cites
- 2474US9938333B2Modified leptin polypeptides and their usesKRAYNOV VADIM·Filed 2009·Granted Apr 10, 2018·2 cites·9 claims
- 2571US10138283B2Modified bovine G-CSF polypeptides and their usesHAYS PUTNAM ANNA MARIA A·Filed 2009·Granted Nov 27, 2018·2 cites·4 claims
- 2666US11542310B2Modified bovine G-CSF polypeptides and their usesAMBRX INC·Filed 2018·Granted Jan 3, 2023·0 cites·6 claims
- 2766US2014296487A1Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesSHEFFER JOSEPH·Filed 2013·Application pending·0 cites
- 2863US2011015345A1Modified FGF-23 Polypeptides and Their UsesAMBRX INC·Filed 2009·Application pending·0 cites
- 2961US2011207914A1Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesAMBRX INC·Filed 2011·Application pending·0 cites
- 3060US2012041180A1Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesSHEFFER JOSEPH·Filed 2011·Application pending·0 cites
- 3158US2022033518A1Prostate-specific membrane antigen antibody drug conjugatesAMBRX INC·Filed 2020·Application pending·0 cites
- 3254US2009018029A1Methods and Compositions Comprising Non-Natural Amino AcidsAMBRX INC·Filed 2006·Application pending·0 cites
- 3354US2015152159A1Modified bovine somatotropin polypeptides and their usesAMBRX INC·Filed 2014·Application pending·0 cites
- 3452US2015299288A1Modified Insulin Polypeptides and Their UsesAMBRX INC·Filed 2014·Application pending·0 cites
- 3551US2010135959A1Human Interferon Molecules and Their UsesAMBRX INC·Filed 2006·Application pending·0 cites
- 3649US2011195899A1Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino AcidAMBRX INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anna-Maria A. Hays Putnam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →